AMDL warns that funds will dry up in three months
This article was originally published in Clinica
Executive Summary
AMDL, a US company which manufactures early diagnosis tests for various cancers, has said that it has money left for only three more months. It is looking for further financing, but does not report any positive reactions to its soundings. Its CFO, Harry Berk, has also resigned.